Perrigo Co. PLC Ratings Affirmed On Term Loan B Add-On To Fund Tender Offer; Outlook Stable - S&P Global Ratings’ Credit Research

Perrigo Co. PLC Ratings Affirmed On Term Loan B Add-On To Fund Tender Offer; Outlook Stable

Perrigo Co. PLC Ratings Affirmed On Term Loan B Add-On To Fund Tender Offer; Outlook Stable - S&P Global Ratings’ Credit Research
Perrigo Co. PLC Ratings Affirmed On Term Loan B Add-On To Fund Tender Offer; Outlook Stable
Published Nov 10, 2023
4 pages (2307 words) — Published Nov 10, 2023
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

Perrigo Co. PLC launched a $300 million fungible add-on to its term loan B facility to finance a tender offer for $300 million of its $700 million, 3.9% senior unsecured notes due Dec. 15, 2024. We affirmed all of our ratings on the over-the-counter consumer health care products company, including our 'BB' issuer credit rating, 'BB+' rating on the senior secured bank credit facility (including the upsized term loan B facility), and 'BB-' rating on the senior unsecured notes. The recovery rating on the senior secured bank credit facility remains '2', indicating that lenders could expect substantial (70%-90%; rounded estimate revised to 75% from 85%) recovery in the event of a payment default. The recovery rating on the senior unsecured

  
Brief Excerpt:

...November 10, 2023 - Perrigo Co. PLC launched a $300 million fungible add-on to its term loan B facility to finance a tender offer for $300 million of its $700 million, 3.9% senior unsecured notes due Dec. 15, 2024. - We affirmed all of our ratings on the over-the-counter consumer health care products company, including our '##' issuer credit rating, '##+' rating on the senior secured bank credit facility (including the upsized term loan B facility), and '##-' rating on the senior unsecured notes. - The recovery rating on the senior secured bank credit facility remains '2', indicating that lenders could expect substantial (70%-90%; rounded estimate revised to 75% from 85%) recovery in the event of a payment default. The recovery rating on the senior unsecured notes remains '5', indicating modest (10%-30%; rounded estimate revised to 25% from 20%) recovery. - The stable outlook reflects our confidence that Perrigo will reduce S&P Global Ratings-adjusted leverage below 5x, though likely not...

  
Report Type:

Ratings Action

Issuer
GICS
Pharmaceuticals (35202010)
Sector
Global Issuers
Country
Region
Europe, Middle East, Africa
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Perrigo Co. PLC Ratings Affirmed On Term Loan B Add-On To Fund Tender Offer; Outlook Stable" Nov 10, 2023. Alacra Store. May 21, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Perrigo-Co-PLC-Ratings-Affirmed-On-Term-Loan-B-Add-On-To-Fund-Tender-Offer-Outlook-Stable-3087400>
  
APA:
S&P Global Ratings’ Credit Research. (). Perrigo Co. PLC Ratings Affirmed On Term Loan B Add-On To Fund Tender Offer; Outlook Stable Nov 10, 2023. New York, NY: Alacra Store. Retrieved May 21, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Perrigo-Co-PLC-Ratings-Affirmed-On-Term-Loan-B-Add-On-To-Fund-Tender-Offer-Outlook-Stable-3087400>
  
US$ 150.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.